| | MANUFACTURING CGMP GRADE HYDROXYCOBALAMINE | LEIDOS BIOMEDICAL RESEARCH INC | $61,516 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 12, 2025 | Sep 15, 2025 | Jun 25, 2026 |
| | LEAD OPTIMIZATION OF A LONG NON-CODING RNA (LNCRNA) AS A POTENTIAL LIPID- AND GLUCOSE-LOWERING THERAPEUTIC | LEIDOS BIOMEDICAL RESEARCH INC | $921,875 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 11, 2025 | Sep 15, 2025 | Jun 25, 2026 |
| | STABILITY STUDY SUPPORT OF R-VK4-116 | LEIDOS BIOMEDICAL RESEARCH INC | $98,473 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 11, 2025 | Sep 15, 2025 | Jun 25, 2026 |
| | CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NES-100 AS A NASAL SPRAY OF A NEW ANALGESIC | LEIDOS BIOMEDICAL RESEARCH INC | $1,346,384 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 11, 2025 | Sep 15, 2025 | Jun 25, 2026 |
| | EVALUATION OF IVO COMPOUNDS IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS MODEL | LEIDOS BIOMEDICAL RESEARCH INC | $219,752 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 10, 2025 | Sep 15, 2025 | Jun 25, 2026 |
| | DEVELOP, QUALIFY IMMUNOLOGICAL ASSAYS, AND PROVIDE CLINICAL SAMPLE TESTING FOR AAV-BASED GENE THERAPY CLINICAL CANDIDATES | LEIDOS BIOMEDICAL RESEARCH INC | $2,510,508 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 10, 2025 | Sep 15, 2025 | Jun 25, 2026 |
| | MANUFACTURING PROCESS DEVELOPMENT OF 4-HB | LEIDOS BIOMEDICAL RESEARCH INC | $917,706 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 10, 2025 | Sep 15, 2025 | Jun 25, 2026 |
| | NCI OPERATIONAL TASK ORDER, FY26-FY27 | LEIDOS BIOMEDICAL RESEARCH INC | $805,990,058 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Aug 29, 2025 | Aug 31, 2025 | Aug 30, 2027 |
| | NIAID DCR FY26-27 OPERATIONAL TASK ORDER | LEIDOS BIOMEDICAL RESEARCH INC | $139,889,945 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Aug 28, 2025 | Aug 31, 2025 | Aug 30, 2027 |
| | THE NIAID DIR FY26-27 OPERATIONAL TASK ORDER | LEIDOS BIOMEDICAL RESEARCH INC | $17,912,355 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Aug 28, 2025 | Aug 31, 2025 | Aug 30, 2027 |
| | FY26 FFRDC LEASES | LEIDOS BIOMEDICAL RESEARCH INC | $28,328,200 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Aug 28, 2025 | Aug 31, 2025 | Aug 30, 2026 |
| | NIAID VRC FY26-27 OPERATIONAL TASK ORDER | LEIDOS BIOMEDICAL RESEARCH INC | $87,099,419 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Aug 27, 2025 | Aug 31, 2025 | Aug 30, 2027 |
| | TO-I BUILDING 1021 2ND FLOOR AHU REPLACEMENT | LEIDOS BIOMEDICAL RESEARCH INC | $3,210,882 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Aug 20, 2024 | Aug 20, 2024 | Aug 6, 2026 |
| | FY24 FACILITIES TO C - 126610 B555 CHILLER VFD INSTALL | LEIDOS BIOMEDICAL RESEARCH INC | $813,345 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | May 23, 2024 | May 23, 2024 | Nov 24, 2026 |
| | THE COST PLUS FIXED FEE (CPFF) TO TO REFURBISH AND IMPROVE NCI FREDERICK INFRASTRUCTURE WILL HAVE A BASE AND THREE (3) OPTIONS. | LEIDOS BIOMEDICAL RESEARCH INC | $7,999,585 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 27, 2023 | Sep 27, 2023 | Jul 10, 2026 |
| | FY23 TASK ORDER E - 126330 B320 TRAILER | LEIDOS BIOMEDICAL RESEARCH INC | $2,266,630 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 27, 2023 | Sep 27, 2023 | Aug 31, 2026 |
| | FY23 TASK ORDER H - 126361 WEDGEWOOD SUITE M & N EXPANSION | LEIDOS BIOMEDICAL RESEARCH INC | $16,398,667 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 27, 2023 | Sep 27, 2023 | Jun 18, 2026 |
| | DRUG PRODUCT FORMULATION DEVELOPMENT, GMP MANUFACTURE, AND LONG-TERM STABILITY STUDIES OF BITOX FOR PHASE I CLINICAL TRIALS | LEIDOS BIOMEDICAL RESEARCH INC | $1,649,757 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 5, 2023 | Sep 15, 2023 | Sep 14, 2026 |
| | INSILICO AND EX-VIVO IMMUNOGENICITY ANALYSIS OF NCATS GENE THERAPY TEST | LEIDOS BIOMEDICAL RESEARCH INC | $1,361,419 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Jun 28, 2023 | Jul 3, 2023 | Jul 2, 2026 |
| | THIS COST PLUS FIXED FEE TASK ORDER IS FOR COORDINATED FACILITIES REQUIREMENTS FOR FY22 FACILITIES BAS UPGRADE | LEIDOS BIOMEDICAL RESEARCH INC | $3,596,890 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 23, 2022 | Sep 26, 2022 | Jul 20, 2026 |
| | LONGITUDINAL STUDIES OF DOGS WITH CANCER AS A COMPARATIVE ONCOLOGY MODEL | LEIDOS BIOMEDICAL RESEARCH INC | $3,323,184 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 8, 2022 | Sep 9, 2022 | Sep 8, 2026 |
| | GS-524 PHASE 1 TRIAL | LEIDOS BIOMEDICAL RESEARCH INC | $4,686,999 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Jan 7, 2022 | Jan 7, 2022 | Jul 6, 2026 |
| | INFRASTRUCTURE IMPROVEMENTS | LEIDOS BIOMEDICAL RESEARCH INC | $4,082,230 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 25, 2021 | Sep 27, 2021 | Sep 24, 2026 |
| | WEDGEWOOD EXPANSION DESIGN SUITES M & N | LEIDOS BIOMEDICAL RESEARCH INC | $7,763,273 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | M1HAOPERATION OF GOVERNMENT-OWNED CONTRACTOR-OPERATED (GOCO) R&D FACILITIES | Sep 20, 2021 | Sep 20, 2021 | Aug 19, 2026 |
| | ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT | LEIDOS BIOMEDICAL RESEARCH INC | $9,972,144 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | Sep 16, 2021 | Sep 16, 2021 | Sep 15, 2026 |